RT Journal Article
SR Electronic
T1 Developing Radiopharmaceuticals
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 65
OP 71
VO 12
IS 2
A1 Plankey, Michael W.
A1 Lind, Sharon
A1 English, Robert J.
A1 Holman, B. Leonard
YR 1984
UL http://tech.snmjournals.org/content/12/2/65.abstract
AB This is the second of a series of continuing education articles on radiopharmaceuticals. After reading and studying this article, the nuclear medicine technologist will be able to: (1) identify the clinical utility of each new radiopharmaceutical described; and (2) discuss technical considerations, such as amount of activity administered, imaging times, radiation dosage, and pitfalls of each. New radiotracers will play an important role in the future of nuclear medicine. This article discusses the technical aspects and potential clinical efficacy of three new radiotracers: gold-195m, iodine-123 amphetamines, and technetium-99m DTPA aerosols.